Literature DB >> 2386373

In vitro susceptibility of Campylobacter jejuni to rokitamycin.

Y Miyake1, M Okada, M Sasaki, N Nagasaka, H Suginaka.   

Abstract

The susceptibilities of 100 clinical isolates of Campylobacter jejuni to rokitamycin, a new macrolide, and eight other oral antibiotics were tested by using a broth microdilution method. Rokitamycin demonstrated antibacterial activity that was higher than those of fosfomycin and the tetracyclines and comparable to those of erythromycin and clindamycin, whereas it was slightly less active than the quinolones.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2386373      PMCID： PMC175996          DOI： 10.1128/AAC.34.7.1440

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  Mechanisms of antibiotic resistance in Campylobacter species.

Authors:  D E Taylor; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

2.  Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli.

Authors:  R Burridge; C Warren; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

3.  In vitro reversal of antibiotic resistance by ethylenediamine tetraacetic acid.

Authors:  R Weiser; A W Asscher; J Wimpenny
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

4.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

5.  Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3"-O-acyl derivatives of leucomycin.

Authors:  H Sakakibara; O Okekawa; T Fujiwara; M Aizawa; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1981-08       Impact factor: 2.649

6.  Acyl derivatives of 16-membered macrolides. I. Synthesis and biological properties of 3"-O-propionylleucomycin A5 (TMS-19-Q).

Authors:  H Sakakibara; O Okekawa; T Fujiwara; M Otani; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1981-08       Impact factor: 2.649

7.  Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.

Authors:  W L Wang; L B Reller; M J Blaser
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

8.  Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds.

Authors:  Z Elharrif; F Mégraud; A M Marchand
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191
  8 in total
  1 in total

1.  Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

Authors:  H Adler-Mosca; J Lüthy-Hottenstein; G Martinetti Lucchini; A Burnens; M Altwegg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.